Indena SpA

About Indena SpA

Indena is very well known as a leading API contract developer and supplier. Funded in Italy in 1921, the company is privately owned and serving the global markets with its 4 manufacturing plants. The technological offer covers APIs of botanical, fermentation and synthetic origin, with a unique expertise for HPAPIs. Capitalizing on its twenty year experience in handling HPAPIs development and manufacturing at large industrial scale, an additional new kilolab (LK2), designed to handle the production of highly toxic substances endowed with an OEL of 20 ng/m3 (including toxins for ADCs), was opened in 2018; given the market success, it is now undergoing capacity doubling . Additionally, Indena has opened in 2019 a pilot pharmaceutical plant featuring all the technologies available at Indena, to support clinical APIs and small commercial supplies, with a high degree of flexibility. Besides, a multipurpose fermentation suite (20 thousand liter capacity) is available with the possibility to handle toxic compounds. As far as Spray Drying is concerned, Indena has available two...

  • IT
  • 2015
    On CPHI since
  • 500 - 999
    Employees
Company types
Manufacturer/Innovator
Contact info
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Frankfurt, Germany
1-3 November 2022

Products from Indena SpA (5)

  • 10-Deacetylbaccatin III

    Product 10-Deacetylbaccatin III

    Indena SpA offers a wide range of pharmaceutical products which include 10-deacetylbaccatin III. Botanical origin: taxus baccata l.twig and leaf. Biological activity: chemical intermediate.
  • 18β-GA

    Product 18β-GA

    Indena SpA offers a wide range of pharmaceutical products which includes 18β-GA. Botanical origin: Glycyrrhiza glabra L. Biological activity: Anti-inflammatory. Contact us for more information.
  • Alder Buckthorn Extract

    Product Alder Buckthorn Extract

    Indena SpA offers a wide range of pharmaceutical products which includes alder buckthorn extract. Botanical origin: frangula alnus miller (rhamnus frangula l.) bark. Biological activity: laxative. Contact us for more information.
  • Artichoke Leaf Extract

    Product Artichoke Leaf Extract

    Indena SpA offers a wide range of pharmaceutical products which includes artichoke leaf extract. Botanical origin: cynara cardunculus l. leaf. Biological activity: anti-dyspeptic, choleretic, hypocholesterolemic. Contact us for more information.
  • Boldine

    Product Boldine

    Indena SpA offers a wide range of pharmaceutical products which includes boldine. Botanical origin: peumus boldus molina bark. Biological activity: choleretic. Contact us for more information.

Indena SpA Resources (6)

  • Brochure CDMO services

    Discover how Indena can be considered your ideal innovation partner for CDMO services.
  • Whitepaper Spray Drying services

    Indena offers SD services from organic solvents (also in the presence of excipients). Equipped with two industrial SDs, the company is further investing in a smaller equipment dedicated to HIPOs.
  • Video Indena at CPHI WorldWide 2017

    Have a look at the interview with Indena and their BD & Licensing Director, Stefano Togni. In the interview she talks about, among other things, their facilities around the world and what updates they have to offer.
  • Podcast Podcast: HPAPI Manufacturing: Challenges, Solutions & Innovations

    This session was originally broadcast as part of the CPHI Worldwide 2021 digital content programme. Growth in the highly potent active pharmaceutical ingredients segment means there is strong demand for specialist outsourcing solutions for their manufacture. CDMOs don’t just need to have the right equipment and facilities; they also need to convince sponsors that they possess the in-depth knowledge of safety practices and containment technology. In this CPHI Worldwide podcast with Carlo Aloni, Production and Process Technology Director at Indena, we looked at the various challenges of HPAPI production, the latest innovative technologies and what Indena is currently working towards in this highly promising growth sector.
  • Podcast Podcast - CDMO Capabilities in Challenging Times

    This podcast was originally broadcast as part of the CPHI Worldwide 2021 digital content programme. When a pharmaceutical sponsor company decides it wishes to outsource vital functions such as manufacturing, drug development, and formulation, they are looking for several key qualities in a service provider. CDMOs need to provide flexibility, collaboration and innovation, as well as the ability to continuously evolve their offering. In this CPHI Worldwide podcast with Stefano Togni, Business Development Director at Indena, we explore how CDMOs are adapting to changing market conditions amid these challenging times.
  • Podcast Podcast: Resilience and Sustainability – 100 years of Indena and Reflections on 2021

    This session was originally broadcast as part of the CPHI Worldwide 2021 digital content programme. 2021 has been the second year of a very difficult and challenging global pandemic, to which the pharmaceutical industry has had to respond with resilience and flexibility. Coincidentally, it is also the centenary year of API contract developer and supplier, Indena. In this CPHI Worldwide podcast with Francesca de Rensis, Marketing Director at Indena, we take a look back at the proud 100 years of history that have shaped the company into the international business it is today as well as examining the main supply chain challenges facing that have defined the year 2021.